These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2009-016449-24 Regeneración del cartílago articular en gonartrosis de IIº y IIIer grados mediante infiltración articular de Xcel-m-condro-alfa* *Células progenitoras mesenquimales de médula ósea autóloga, expandida... bad-data
Exempt, with results 2011-006270-13 A phase I-IIa safety and efficacy pilot clinical trial of intraarticular administration of autologous mesenchymal stem cells in meniscus injury Estudio clínico piloto de fase I-IIa de seguridad y e... 2017-03-04 not-yet-due
Exempt, with results 2012-000734-19 Treatment of autologous mesenchymal stem cells derived from bone marrow as a potential therapeutic strategy for the treatment of multiple sclerosis Tratamiento con Células Troncales Mesenquimales A... 2019-09-25 not-yet-due
Reported results 2013-005025-23 A phase IIa, unicenter, prospective, randomized, parallel, two-arms, single-dose, open-label with blinded assessor pilot clinical trial to assess ex vivo expanded adult autologous mesenchymal stromal ... 2019-03-05 due-trials
Exempt Terminated 2015-000510-22 CLINICAL EFFICACY OF PLATELET GEL FROM CORD BLOOD FOR THE TREATMENT OF DIABETIC FOOT ULCERS EFICACIA CLÍNICA DEL GEL DE PLAQUETAS DE SANGRE DE CORDÓN UMBILICAL PARA EL TRATAMIENTO DE ÚLCERAS DEL PI... not-yet-due
Exempt 2015-005786-23 A phase I/IIa, randomized, double-blind, single-dose, placebo controlled, two-way crossover clinical trial to assess the safety and to obtain efficacy data in intrathecal administration of expanded Wh... not-yet-due
Exempt, with results Terminated 2016-001841-23 A multicenter, randomized, open-label, two-arms phase I/II clinical trial to asses efficacy and safety of cord blood eye drops in neurotrophic keratopathy Estudio clínico de fase I/II, multicéntric... 2020-03-12 not-yet-due
Exempt 2018-000911-25 A prospective multicenter open, not controlled phase Ib-II clinical trial to assess the safety and immunologic efficacy of virus-specific T lymphocytes from the best donor in receptors of hematopoieti... not-yet-due
Completed, but no date 2018-001867-22 TRANSFUSION OF RED BLOOD CELLS, TRANEXAMIC ACID AND FIBRINOGEN CONCENTRATE FOR SEVERE TRAUMA HEMORRHAGE AT PRE-HOSPITAL PHASE OF CARE. A PILOT TRIAL. Estudio PILOTO sobre los efectos de la transfus... bad-data
Exempt, with results 2020-001505-22 Double-blind, randomized, parallel, placebo-controlled pilot clinical trial, nested in a prospective cohort observational study, for the evaluation of the efficacy and safetyof two doses of WJ-MSC in ... not-yet-due
Exempt 2021-000346-18 A phase I/II, randomized, double-blind, placebo-controlled, parallel, 2-arms clinical trial to assess the safety and efficacy of intrathecal administration of WJ-MSC in chronic traumatic cervical inco... not-yet-due